Fairmount Funds Management, 10% Owner: Cogent Biosciences COGT Buy · Filed 23/06/13

Trade details

Type: Insider buy
Amount: $9,600,000
Shares · price: 800,000 sh · $12.00 a share
Held after: 3,272,124 sh
Stock: Cogent Biosciences COGT
Person: Fairmount Funds Management10% Owner
Trade date: 23/06/09
Filed: 23/06/13
Days to filing: 4 days

Holdings up 32.4%

Insiders buying this week: 1 insiders
Holding change: +32.4%

Cogent Biosciences trades, last 26 weeks

What else happened in Cogent Biosciences around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Fairmount Funds Management's recent trades

Fairmount Funds ManagementDirector, 10% Stockholder
Planned saleOruka Therapeutics
Planned sale
Oruka Therapeutics
ORKA
$300M
3,553,410 sh
$300M
Filed 07/01
Traded 07/01
Fairmount Funds ManagementDirector
Planned saleSpyre Therapeutics
Planned sale
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Fairmount Funds ManagementDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Fairmount Funds ManagementDirector
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
Fairmount Funds ManagementDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31

Fairmount Funds Management, 10% Owner — bought $9.6M of Cogent Biosciences COGT · 800,000 sh @ $12.00 | Whalegun